Literature DB >> 1174637

A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.

G Lagrue, S Xheneumont, A Branellec, G Hirbec, B Weil.   

Abstract

P.H.A. and Concanavalin A stimulated lymphocytes culture supernatants were comparatively studied in 23 volontary normals and in 46 patients with nephrotic syndrome. Intradermal injections to guinea-pig demonstrated a permeability increasing and pro-inflammatory factor. Vascular permeability (immediate reaction) is determinated by blue Evans technique. Delayed reaction is assesed by the cutaneous inflammatory process (erythema, induration); pathologically it is defined as polymorphonuclear and mononuclear infiltration. Differences are highly significant between nephrotic patients and normal subjects. This biological activity is not observed with control supernatants (medium plus normal human serum and P.H.A. or Conca A). Positive results were also found with M.E.M. eagle culture supernatants of nephrotic stimulated lymphocytes. To date lymphokines have been studied especially in animals. In human, they have been found only after concentration. Variations in lymphokine production may be present in some pathologic states.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174637

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  33 in total

Review 1.  Role of circulating soluble immune complexes in disease.

Authors:  R J Levinsky
Journal:  Arch Dis Child       Date:  1978-02       Impact factor: 3.791

Review 2.  Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptor.

Authors:  Hernán Trimarchi
Journal:  World J Nephrol       Date:  2013-11-06

3.  Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.

Authors:  Mukut Sharma; Jianping Zhou; Jean-François Gauchat; Ram Sharma; Ellen T McCarthy; Tarak Srivastava; Virginia J Savin
Journal:  Transl Res       Date:  2015-03-16       Impact factor: 7.012

Review 4.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 5.  The immune system in minimal change nephrotic syndrome.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

6.  Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A.

Authors:  A Meyrier; P Simon; G Perret; M C Condamin-Meyrier
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-22

7.  Nephrotic syndrome of childhood: malaria therapy reconsidered.

Authors:  T M Barratt
Journal:  Arch Dis Child       Date:  1979-11       Impact factor: 3.791

8.  Mononuclear-cell subsets in human idiopathic crescentic glomerulonephritis (ICGN): analysis in tissue sections with monoclonal antibodies.

Authors:  I Stachura; L Si; T L Whiteside
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

Review 9.  Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis : an update of treatment options for children.

Authors:  Jochen H H Ehrich; Lars Pape; Mario Schiffer
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Pathophysiological lessons from rare associations of immunological disorders.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Pediatr Nephrol       Date:  2008-10-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.